Moderna says FDA delayed RSV vaccine approval to end of May

Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to “administrative constraints” at the agency.

The FDA was expected to make a decision on the RSV shot on Sunday. The agency has not informed Moderna of any issues related to the vaccine’s safety, efficacy or quality that would prevent its approval, the biotech company said in a release.that highlights survey data on topics on which Americans largely agree. Its goal is to correct political misperceptions, highlight common ground, and help people feel calmer and more united.

"say it is at least somewhat important that health insurance companies are prohibited from charging sick people higher premiums than healthy people even if the Affordable Care Act is ruled unconstitutional by the Supreme Court." Could the FDA ban chemical in decaf coffee? Agency is looking into whether substance used by Starbucks and Dunkin' Donuts to strip out caffeine may cause CANCER

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna says FDA delayed RSV vaccine approval to end of MayThe FDA has not informed Moderna of any issues related to the vaccine's safety, efficacy or quality that would prevent its approval, the biotech company said.
Source: CNBC - 🏆 12. / 72 Read more »

Moderna says FDA delayed RSV vaccine approval to end of MayThe FDA has not informed Moderna of any issues related to the vaccine’s safety, efficacy or quality that would prevent its approval, the biotech company…
Source: NBCLA - 🏆 319. / 59 Read more »

Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fallModerna beats estimates in Q1 2024, targets RSV vaccine launch in fall
Source: Investingcom - 🏆 450. / 53 Read more »

Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fallModerna beats estimates in Q1 2024, targets RSV vaccine launch in fall
Source: Investingcom - 🏆 450. / 53 Read more »

FDA moves to regulate some tests it says may be unreliableThe FDA has finalized a divisive plan to regulate some lab tests, including those used to diagnose cancer and Alzheimer’s, over concerns about reliability and risk to patients.
Source: adndotcom - 🏆 293. / 63 Read more »

FDA moves to regulate some tests it says may be unreliableThe FDA has finalized a divisive plan to regulate some lab tests, including those used to diagnose cancer and Alzheimer’s disease, over concerns about reliability and risk to patients.
Source: washingtonpost - 🏆 95. / 72 Read more »